Key result
Transfemoral transcatheter aortic valve replacement enabled successful orthotopic liver transplantation and discharge home in a patient with severe mixed aortic valve disease and Child-Pugh Class C liver disease.
Case Report (n=1)
TAVR can be successfully performed in patients with severe aortic valve disease and end-stage liver disease to facilitate subsequent liver transplantation.
The American Association for the Study of Liver Diseases practice guidelines list severe cardiac disease as a contraindication to liver transplantation. Transcatheter aortic valve replacement has been shown to decrease all-cause mortality in patients with severe aortic stenosis who are not considered candidates for surgical aortic valve replacement. We report our experience of liver transplantation in a patient with severe aortic stenosis and moderate aortic insufficiency who underwent transcatheter aortic valve replacement with Child-Pugh Class C disease at a Model For End-Stage Liver Disease score of 29. The patient had a difficult post procedure course that was successfully medically managed. After liver transplantation the patient was discharged to home on postoperative day 11. The combination of cardiac disease and end stage liver disease is challenging but these patients can have a successful outcome despite very severe illness.
No takes yet. Share an insight, caveat, or question.
Wilkey et al. (2015) conducted a case report in Mixed aortic valve disease and Child's Class C liver disease (n=1). Transfemoral Transcatheter Aortic Valve Replacement was evaluated. Transfemoral transcatheter aortic valve replacement enabled successful orthotopic liver transplantation and discharge home in a patient with severe mixed aortic valve disease and Child-Pugh Class C liver disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: